查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1800794

脈絡膜新生血管市場報告（按產品類型、診斷（螢光素血管攝影、吲哚菁綠血管攝影、光譜域光學相干斷層掃描等）、治療類型、應用和地區）2025 年至 2033 年

Choroidal Neovascularization Market Report by Product Type, Diagnosis (Fluorescein Angiography, Indocyanine Green Angiography, Spectral Domain Optical Coherence Tomography, and Others), Treatment Type, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 124 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球脈絡膜新生血管市場規模達 69 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 122 億美元，2025-2033 年期間的成長率 (CAGR) 為 6.13%。

脈絡膜新生血管 (CNV) 是指眼部脈絡膜層新生血管，影響布魯赫膜和視網膜色素上皮 (RPE)。其症狀包括脂質滲出、視網膜下積血和積液，以及中央視野扭曲、出現波紋和黑點。目前，醫生會結合螢光素血管攝影 (FA)、吲哚菁綠 (ICG) 血管攝影和光學相干斷層掃描 (OCT) 等技術來診斷 CNV。醫生會根據檢查結果開立抗血管內皮生長因子 (VEGF) 藥物、熱雷射治療和光動力療法 (PDT)，以阻止血管生長。

由於老年性黃斑部病變 (ARMD)、眼組織胞漿菌病、病理性近視、血管樣條紋、脈絡膜撕裂以及脈絡膜和視網膜發炎性疾病的盛行率不斷上升，市場正在經歷成長。此外，老年人口的不斷成長，使他們更容易患上嚴重的健康問題，這也是推動市場成長的另一個關鍵因素。此外，聯合用藥的日益普及，以及長效抗VEGF藥物的推出，正在推動全球對脈絡膜新生血管 (CNV) 治療的需求。醫療基礎設施的改善以及研發 (R&D) 活動投資的增加等其他因素也促進了市場的成長。

本報告回答的關鍵問題：

  • 全球脈絡膜新生血管市場迄今表現如何，未來幾年將如何表現？
  • COVID-19 對全球脈絡膜新生血管市場有何影響？
  • 主要的區域市場有哪些？
  • 根據產品類型，市場是如何分類的？
  • 根據診斷類型，市場是如何分類的？
  • 根據治療類型，市場是如何分類的？
  • 根據應用，市場詳細情形如何？
  • 該產業的價值鏈分為哪些階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球脈絡膜新生血管市場的結構是怎麼樣的？主要參與者是誰？
  • 產業競爭程度如何？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球脈絡膜新生血管市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品類型

  • 靜脈
  • 玻璃體內

第7章：市場區隔：依診斷類型

  • 螢光素血管攝影（FA）
  • 吲哚菁綠（ICG）血管攝影
  • 頻域光學相干斷層掃描（OCT）
  • 其他

第8章：市場區隔：依治療類型

  • 血管新生抑制劑注射液
  • 光動力療法
  • 雷射光凝
  • 低劑量放射治療
  • 手術

第9章：市場區隔：依應用

  • 極度近視
  • 惡性近視變性
  • 與年齡相關的發展

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 11 章：SWOT 分析

第 12 章：價值鏈分析

第 13 章：波特五力分析

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Bausch Health Companies Inc.
    • Bayer AG
    • Gilead Sciences, Inc.
    • F. Hoffmann-La Roche AG
    • MaaT Pharma
    • Novartis AG
    • Pfizer Inc.
    • Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
    • Regeneron Pharmaceuticals Inc.
    • Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
Product Code: SR112025A2561

The global choroidal neovascularization market size reached USD 6.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.13% during 2025-2033.

Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.

The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market.

Key Market Segmentation:

Breakup by Product Type:

  • Intravenous
  • Intravitreal

Breakup by Type of Diagnosis:

  • Fluorescein Angiography (FA)
  • Indocyanine Green (ICG) Angiography
  • Spectral Domain Optical Coherence Tomography (OCT)
  • Others

Breakup by Treatment Type:

  • Angiogenesis Inhibitors Injection
  • Photodynamic Therapy
  • Laser photocoagulation
  • Low-dose Radiation Therapy
  • Surgery

Breakup by Application:

  • Extreme Myopia
  • Malignant Myopic Degeneration
  • Age-Related Developments

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).

Key Questions Answered in This Report:

  • How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global choroidal neovascularization market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the type of diagnosis?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global choroidal neovascularization market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Choroidal Neovascularization Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Intravenous
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intravitreal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type of Diagnosis

  • 7.1 Fluorescein Angiography (FA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Indocyanine Green (ICG) Angiography
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Spectral Domain Optical Coherence Tomography (OCT)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Treatment Type

  • 8.1 Angiogenesis Inhibitors Injection
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Photodynamic Therapy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Laser Photocoagulation
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Low-dose Radiation Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Surgery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Extreme Myopia
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Malignant Myopic Degeneration
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Age-Related Developments
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bausch Health Companies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Gilead Sciences, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 MaaT Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Novartis AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Regeneron Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
  • Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2024
  • Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2024
  • Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
  • Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
  • Figure 87: Global: Choroidal Neovascularization Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million USD), 2025-2033
  • Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Choroidal Neovascularization Market Structure
  • Table 8: Global: Choroidal Neovascularization Market: Key Players